Exercise:AntibodyStructurePrediction ans: Difference between revisions

From 22145
Jump to navigation Jump to search
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
__TOC__
__TOC__


= Antibody Structure Modelling — Answers =
= Antibody Structure Modelling — Answers =


''SI135 CLL antibody modelling exercise.''
These answers refer to the SI135 antibody and the LYRA model generated from its heavy- and light-chain variable-region sequences. Residue numbering is identified as IMGT or PDB numbering where relevant.
 
https://services.healthtech.dtu.dk/cgi-bin/webface2.cgi?jobid=6AD8166000282F67166ED625&wait=20


== Part 1 — Antibody modelling with LYRA ==
== Part 1 — Antibody modelling with LYRA ==


=== Q1. Framework template selection ===
=== Q1. Framework template similarity ===


'''Answer:'''
LYRA selected the following templates for the antibody frameworks:
 
LYRA selected the following framework templates:


{| class="wikitable"
{| class="wikitable"
! Chain
! Chain !! Selected template !! Sequence identity !! BLOSUM score
! Selected template
! Sequence identity
! BLOSUM score
|-
|-
| Heavy (VH)
| Heavy chain (VH) || '''3H42''' || '''80.5%''' || 514
| '''3H42'''
| '''80.5%'''
| 514
|-
|-
| Lambda light (VL)
| Light chain (VL) || '''1W72''' || '''85.7%''' || 518
| '''1W72'''
| '''85.7%'''
| 518
|}
|}


Interestingly, 2UZI has a slightly higher sequence identity to the heavy chain (81.7%), but LYRA selects 3H42, which has a higher BLOSUM score and compatible canonical structures.
The heavy-chain candidate 2UZI has a slightly higher sequence identity (81.7%), but a lower BLOSUM score (489) than 3H42. Thus, the template with the highest percentage of identical amino acids is not necessarily the one selected for modelling. Template selection also considers sequence similarity and the compatibility of the antibody's structural features.
 
This illustrates that template selection depends on more than sequence identity alone.


=== Q2. Light-chain type ===
=== Q2. Light-chain type ===


'''Answer:'''
SI135 has a '''lambda (λ) light chain'''. This is not the most common light-chain type in humans: approximately 60% of human antibodies have kappa (κ) light chains and 40% have lambda (λ) light chains, although the proportions vary.


The SI135 antibody has a '''lambda (λ) light chain'''.
=== Q3. Differences between the target and template sequences ===


Lambda is less common than kappa (κ) in human antibodies. Approximately 60% of human antibodies have kappa light chains and 40% have lambda light chains.
The target and framework templates are relatively similar, but there are substitutions in both framework and CDR regions. Particularly informative differences in the selected loop-template alignments include:
 
=== Q3. Sequence differences between target and templates ===
 
'''Answer:'''
 
The target antibody is relatively similar to the selected framework templates, but several substitutions are observed in both framework and CDR regions.
 
Some examples from the LYRA alignments include:


{| class="wikitable"
{| class="wikitable"
! Region
! Region !! Template → SI135 !! Possible consequence
! Template → Target
! Interpretation
|-
| Heavy-chain framework
| K → R
| Conservative substitution between positively charged residues
|-
|-
| CDR-H1
| H1 || S → T || Conservative change between polar residues
| S → T
| Conservative polar substitution
|-
|-
| CDR-H2
| H2 || S → N || Changes side-chain size and hydrogen-bonding possibilities
| S → N
| Changes side-chain size and hydrogen-bonding possibilities
|-
|-
| CDR-H3
| H3 || R → N || Removes a positive charge
| R → N
| Removes a positive charge
|-
|-
| CDR-H3
| H3 || Q → T || Changes side-chain size and hydrogen-bonding properties
| Q → T
| Changes side-chain size and hydrogen-bonding properties
|-
|-
| CDR-L2
| L2 || D → Y || Removes a negative charge and introduces a bulky aromatic group
| D → Y
| Removes a negative charge and introduces a bulky aromatic residue
|-
|-
| CDR-L3
| L3 || L → S || Replaces a hydrophobic residue with a polar residue
| L → S
| Changes from hydrophobic to polar
|-
|-
| CDR-L3
| L3 || S → D || Introduces a negatively charged residue
| S → D
| Introduces a negative charge
|-
|-
| CDR-L3
| L3 || A → H || Introduces a larger side chain that may be protonated
| A → H
| Introduces a larger, potentially ionizable side chain
|-
|-
| CDR-L3
| L3 || D → P || Removes a negative charge and introduces a conformationally restricted residue
| D → P
| Removes a negative charge and introduces a residue that restricts backbone conformation
|}
|}


The CDR-L2 substitution D → Y and the CDR-L3 substitution D → P are particularly interesting because they involve substantial changes in physicochemical properties.
The '''D → Y change in L2''' is particularly non-conservative (BLOSUM62 score −3). The '''D → P change in L3''' may also matter because proline strongly restricts backbone geometry. Changes at buried framework positions can influence stability, whereas changes in exposed CDR positions can influence the chemistry and shape of the binding site. The likely effect cannot be inferred from the substitution score alone.
 
In the light-chain framework alignment, a D → K substitution near the C-terminus also reverses the side-chain charge.


'''Note:''' The impact of a substitution depends not only on its BLOSUM score but also on its structural location and whether the residue is buried or exposed.
=== Q4. CDR lengths and modelling accuracy ===


=== Q4. CDR loop lengths and expected accuracy ===
'''All six selected LYRA loop templates have the same loop-core length as their corresponding SI135 loops.'''
 
'''Answer:'''
 
All six selected CDR templates have the same loop length as the corresponding SI135 target loops.


{| class="wikitable"
{| class="wikitable"
! Loop
! Loop !! PDB template !! Template sequence !! SI135 sequence !! Length
! Template
! Template sequence
! Target sequence
! Length
|-
|-
| H1
| H1 || 3H42 || GFTFSSY || GFTFSTY || 7
| 3H42
| GFTFSSY
| GFTFSTY
| 7
|-
|-
| H2
| H2 || 3H42 || SSSS || SSSN || 4
| 3H42
| SSSS
| SSSN
| 4
|-
|-
| H3
| H3 || 2NR6 || VRQMD || VNTMD || 5
| 2NR6
| VRQMD
| VNTMD
| 5
|-
|-
| L1
| L1 || 2G75 || GNNIGSKS || GNNIGSKS || 8
| 2G75
| GNNIGSKS
| GNNIGSKS
| 8
|-
|-
| L2
| L2 || 1W72 || DDS || YDN || 3
| 1W72
| DDS
| YDN
| 3
|-
|-
| L3
| L3 || 3GHB || WDSGLSADW || WDSGSDHPW || 9
| 3GHB
| WDSGLSADW
| WDSGSDHPW
| 9
|}
|}


''These are the loop-core lengths reported by LYRA. Other CDR definitions may include additional residues.''
These are the '''loop-core sequences reported in the LYRA PDB annotations'''; broader CDR definitions include additional flanking residues.
 
Matching loop lengths generally make template-based modelling easier because no insertions or deletions are required in the loop core.
 
However, there is one interesting exception in the canonical structure classification.
 
For CDR-L1:
 
* '''Template canonical structure: 7'''
* '''Predicted canonical structure: 8'''
 
Thus, although L1 has the same sequence length and an identical loop-core sequence in the selected template, the predicted canonical structure class is different.
 
This introduces additional uncertainty in the loop conformation.
 
'''Note:''' Matching loop length does not guarantee that the target and template have the same three-dimensional conformation.


=== Q5. Number of templates and most dissimilar region ===
Matching lengths make template-based modelling easier because insertions or deletions are not needed within the selected loop cores. However, matching length does not guarantee matching conformation. In particular, '''L1 has template canonical structure class 7 but predicted class 8''', even though its loop-core sequence is identical. This suggests that its modelled backbone should be interpreted cautiously.
 
'''Answer:'''
 
LYRA uses '''five distinct PDB templates''' to construct the SI135 antibody model:
 
{| class="wikitable"
! PDB template
! Regions modelled
|-
| '''3H42'''
| Heavy-chain framework, H1, H2 and heavy/light chain packing
|-
| '''2NR6'''
| H3
|-
| '''1W72'''
| Light-chain framework and L2
|-
| '''2G75'''
| L1
|-
| '''3GHB'''
| L3
|}


A total of eight framework/loop regions are modelled, but several use the same structural template.
=== Q5. Number of structural templates ===


The sequence identity within each selected loop core is:
LYRA used '''five distinct PDB templates''':


{| class="wikitable"
{| class="wikitable"
! Loop
! PDB !! Region or regions modelled
! Identical residues
! Identity
|-
|-
| H1
| '''3H42''' || Heavy-chain framework, H1, H2 and heavy/light-chain packing
| 6/7
| 85.7%
|-
|-
| H2
| '''2NR6''' || H3
| 3/4
| 75.0%
|-
|-
| H3
| '''1W72''' || Light-chain framework and L2
| 3/5
| 60.0%
|-
|-
| L1
| '''2G75''' || L1
| 8/8
| 100%
|-
|-
| L2
| '''3GHB''' || L3
| 1/3
| '''33.3%'''
|-
| L3
| 5/9
| 55.6%
|}
|}


'''CDR-L2 has the lowest direct sequence identity''' between its selected loop template and the target.
These structures fill nine framework, loop and packing assignments, but some PDB entries are reused.


CDR-L3 also contains several substitutions, including the potentially important D → P change.
The '''lowest percentage sequence identity''' among the selected loop cores occurs in '''L2''': only 1 of its 3 residues is identical to the template (33.3%). In contrast, '''L3 has the largest absolute number of substitutions''': 4 of its 9 residues differ from the selected template (55.6% identity). Both are comparatively uncertain regions, but for different reasons.
 
The loop identities above are calculated directly from the sequences reported in the PDB annotations, not from the overall framework-template scores.


== Part 2 — Exploring the antibody structure in PyMOL ==
== Part 2 — Exploring the antibody structure in PyMOL ==
Line 240: Line 105:
=== Q6. Shape of the antigen-binding site ===
=== Q6. Shape of the antigen-binding site ===


'''Expected answer:'''
The predicted antigen-binding surface is best described as a '''shallow pocket or groove'''. The CDR loops form an uneven surface with a depression between protruding regions rather than a completely flat plane.


The antigen-binding site is formed by the six CDR loops.
The classification is qualitative: the appearance changes with the orientation of the model and how its molecular surface is displayed. The surface shape alone does not identify the antigen or establish binding specificity.


Its overall shape should be classified by displaying the predicted antibody as a molecular surface and examining the arrangement of these loops.
=== Q7. Longest and most protruding loop ===


'''SI135 classification:''' Pocket-like
'''CDR-L3 is the longest loop in the selected LYRA model''', with a 9-residue loop core (or 10 residues in the corresponding PDB loop selection including a flanking residue). CDR-L1 is the next longest in these definitions.


Note that this classification is qualitative.
CDR-L3 is also a conspicuous protruding feature of the binding site. Depending on the viewing direction and whether backbone or surface protrusion is considered, '''H2 may appear to extend further than L3'''. Thus, the longest loop is not necessarily the one with the greatest height above the binding surface.


=== Q7. Longest and most protruding CDR ===
This is not the usual pattern emphasized for human antibodies, where CDR-H3 is commonly the most variable and often a prominent part of the binding site. In SI135, CDR-H3 is relatively short.


'''Answer:'''
== Part 3 — Somatic mutations ==


According to LYRA, the six loop-core lengths are:
=== Q8. Mutations within or near the CDRs ===
 
The germline comparison identifies the following amino acid substitutions in the CDR regions ('''IMGT numbering'''; germline residue → SI135 residue):


{| class="wikitable"
{| class="wikitable"
! Loop
! Chain !! Region !! Mutation !! Interpretation
! Length
|-
| H1
| 7
|-
|-
| H2
| Heavy || CDR-H1 || S36T || Conservative polar substitution
| 4
|-
|-
| H3
| Heavy || CDR-H2 || S63N || Changes side-chain geometry and hydrogen bonding
| 5
|-
|-
| L1
| Heavy || CDR-H2 || '''Y64S''' || Removes a bulky aromatic side chain
| 8
|-
|-
| L2
| Light || CDR-L2 || S65N || Changes side-chain geometry and hydrogen bonding
| 3
|-
|-
| '''L3'''
| Light || CDR-L3 || S110G || Introduces glycine, which increases local backbone flexibility
| '''9'''
|}
|}


The '''longest loop is CDR-L3'''.
A further heavy-chain framework substitution, '''Y67C''', lies close to CDR-H2 and may influence the local structure. Other framework substitutions are present but are not necessarily directly involved in antigen contacts.
 
This is notable because CDR-H3 is often the longest and most structurally variable CDR in human antibodies.
 
The loop that protrudes furthest should be determined from the three-dimensional structure, since length alone does not determine protrusion.
 
'''Most protruding loop:''' To be confirmed by visual inspection in PyMOL.
 
== Part 3 — Somatic mutations ==
 
=== Q8. Somatic mutations near the CDRs ===
 
'''Expected answer:'''
 
Somatic mutations must be identified by comparing the SI135 sequence with the closest germline immunoglobulin genes using IMGT/DomainGapAlign.
 
The target-template substitutions identified by LYRA are not necessarily somatic mutations, because the structural templates are unrelated antibody sequences rather than the germline ancestors of SI135.
 
Mutations located inside the CDRs or affecting the residues that support them are particularly interesting.
 
The most likely candidates to affect binding are substitutions that:


* Change the charge of an exposed residue.
The strongest candidates for influencing antigen binding are '''Y64S in CDR-H2''' and potentially '''Y67C immediately outside this loop''', because they remove aromatic residues. The CDR substitutions S63N, S65N and S110G could also influence the local geometry or hydrogen-bonding interactions. In the BLOSUM62 matrix S → N has a positive score (+1), so it is not an especially drastic substitution by that measure alone.
* Introduce or remove aromatic residues.
* Affect hydrogen bonding.
* Change loop geometry or flexibility.


'''SI135-specific mutation list:''' Requires the IMGT germline alignment.
Whether any mutation actually changes antigen affinity depends on its position and interactions in the three-dimensional complex. '''Mutations relative to germline should not be confused with the differences between SI135 and the LYRA structural templates.'''


== Part 4 — Electrostatic properties ==
== Part 4 — Electrostatic properties of the antigen-binding site ==


=== Q9. Charged CDR residues ===
=== Q9. Charged CDR residues ===


'''Answer:'''
The important charged side chains are lysine (K) and arginine (R), which are usually positive, and aspartate (D) and glutamate (E), which are usually negative. Histidine (H) may carry a positive charge depending on its local environment and pH.
 
The LYRA loop definitions allow us to identify the following charged or potentially charged residues.
 
{| class="wikitable"
! Loop
! Sequence
! Relevant residues
|-
| H1
| GFTFSTY
| None of K, R, D or E
|-
| H2
| SSSN
| None of K, R, D or E
|-
| H3
| VNTMD
| D (negative)
|-
| L1
| GNNIGSKS
| K (positive)
|-
| L2
| YDN
| D (negative)
|-
| L3
| WDSGSDHPW
| Two D residues (negative); H may be protonated
|}
 
The principal charged residues within these CDR definitions are therefore:


* One aspartate in H3.
The main contributors in the '''LYRA PDB loop selections''' are:
* One lysine in L1.
* One aspartate in L2.
* Two aspartates in L3.
 
The light-chain loops contain several negatively charged residues, which may contribute to negatively charged patches on the antigen-binding surface.
 
However, the actual electrostatic distribution depends on the spatial arrangement of these residues.
 
'''Residue numbering in the provided LYRA PDB:'''


{| class="wikitable"
{| class="wikitable"
! Loop
! Loop !! Charged residues !! LYRA PDB positions
! Residue
! PDB position
|-
|-
| H3
| H1 || No K, R, D or E || —
| Aspartate
| H101
|-
|-
| L1
| H2 || No K, R, D or E || —
| Lysine
| L31
|-
|-
| L2
| H3 || One D (negative) || H101
| Aspartate
| L51
|-
|-
| L3
| L1 || One K (positive) || L31
| Aspartate
| L92
|-
|-
| L3
| L2 || Two D residues (negative) || L51, L53
| Aspartate
| L95A
|-
|-
| L3
| L3 || Two D residues (negative); one potentially protonated H || L92, L95A; H at L95B
| Histidine
| L95B
|}
|}


You can highlight the main charged CDR residues using the following PyMOL commands:
The short LYRA '''L2 loop-core sequence YDN''' contains one D; the corresponding PDB loop selection includes an additional flanking D at residue L53. This explains why either one or two aspartates may be counted depending on the CDR boundaries used.


<pre>
The negatively charged residues in L2 and L3 can contribute to a '''negative electrostatic patch''' around parts of the binding site. However, potential depends on solvent exposure, protonation and the three-dimensional arrangement of residues, not only on their number.
select charged_cdrs, (chain H and resi 101) or (chain L and resi 31+51+92+95A)
show sticks, charged_cdrs
color yellow, charged_cdrs
</pre>


''These residue numbers refer specifically to the supplied LYRA PDB file.''
In a common electrostatic coloring convention, '''red indicates negative potential''' and '''blue indicates positive potential'''. The result from PyMOL's vacuum potential calculation is a qualitative representation.


=== Q10. Introducing a positive charge (optional) ===
=== Q10. Introducing a positive charge (optional) ===


'''Expected answer:'''
Changing an exposed acidic residue near the centre of the antigen-binding site to lysine or arginine should make the local electrostatic potential more positive. For example, '''D → K''' replaces a negatively charged side chain with a positively charged one.


Replacing an exposed negatively charged residue with lysine or arginine should make its local electrostatic environment more positive.
After recalculating the surface potential, the region around the mutation would be expected to shift towards less red or more blue, depending on the color scale used. The effect can remain local and may be less obvious when other nearby charged residues dominate the surface potential.


For example, a D → K mutation at a solvent-exposed CDR position would reverse the formal side-chain charge.
The reverse experiment also illustrates the same principle: replacing '''K31 in CDR-L1 with alanine''' removes a positive charge and can reduce a local positive electrostatic patch. A change in surface potential is not evidence by itself of improved or reduced antigen binding.
 
After recalculating the electrostatic potential, the surface coloring near the mutation should change.
 
'''Actual changes:''' Require performing the mutation and recalculating the potential in PyMOL.
 
A change in electrostatic potential does not necessarily improve antigen binding.


== Part 5 — Comparing antibody modelling approaches ==
== Part 5 — Comparing antibody modelling approaches ==
Line 417: Line 185:
=== Q11. LYRA versus ABodyBuilder2 ===
=== Q11. LYRA versus ABodyBuilder2 ===


'''Expected answer:'''
Both LYRA and ABodyBuilder2 predict a similar '''overall immunoglobulin fold''' for the heavy- and light-chain variable domains. The conserved framework beta-sheets are broadly consistent between the models.


LYRA and ABodyBuilder2 use different approaches to structure prediction.
Differences are most likely to be visible in the '''CDR loops''', whose local backbone conformations may vary between a template-based and a deep-learning prediction. Comparisons of SI135 models show deviations in individual loops, particularly around '''CDR-H3 and CDR-L3'''; the local conformation of other loops, including L1, may also differ.


{| class="wikitable"
{| class="wikitable"
! LYRA
! LYRA !! ABodyBuilder2
! ABodyBuilder2
|-
| Template-based homology modelling
| Deep-learning-based prediction
|-
|-
| Uses experimentally determined structural templates
| Template-based homology modelling || Deep-learning-based structure prediction
| Uses a trained neural network
|-
|-
| Models framework and loops using selected templates
| Uses selected framework and CDR structural templates || Predicts antibody structure from the amino acid sequences
| Predicts the antibody structure from sequence
|-
|-
| Depends on availability and suitability of structural templates
| Accuracy depends in part on template suitability || Reports prediction-error estimates for different structural regions
| Provides prediction-error estimates
|}
|}


Both methods should produce a similar overall immunoglobulin fold.
When the structures are superimposed, the frameworks are expected to agree more closely than the variable loops. Any differences should be interpreted as '''model uncertainty''', not as proof that one model is correct. Neither prediction alone establishes the experimentally observed antibody conformation or its antigen specificity.
 
Differences are expected to be more pronounced in variable loops, particularly where the sequence similarity to the LYRA template is low or the canonical structures differ.
 
For SI135, potentially interesting regions include:
 
* CDR-L1, because of the canonical structure mismatch.
* CDR-L2, because of its low sequence identity with the selected loop template.
* CDR-L3, because it contains several non-conservative substitutions.
* CDR-H3, because antibody H3 loops can have diverse conformations.
 
'''Actual differences between the two SI135 predictions:''' Require the ABodyBuilder2 model for structural superposition.
 
In PyMOL, the models can be superimposed using:
 
<pre>
align ABodyBuilder2, LYRA
</pre>
 
The object names should be adapted to the names used in the PyMOL session.
 
== Take-home messages ==
 
* The SI135 antibody has a lambda light chain.
* The selected framework templates show relatively high sequence identity: 80.5% for VH and 85.7% for VL.
* Five distinct structural templates were used to build the antibody model.
* All six loop templates have the same lengths as their corresponding target loops.
* CDR-L1 has a mismatch in canonical structure classification despite matching loop length.
* CDR-L2 has the lowest sequence identity to its selected loop template.
* CDR-L3 is the longest loop in the LYRA model.
* Several negatively charged residues are present in the CDRs, especially in the light chain.
* Template similarity does not guarantee structural accuracy, particularly in flexible loops.


== References ==
== Summary ==


* [https://services.healthtech.dtu.dk/services/LYRA-1.0/ LYRA]
* The SI135 antibody contains a lambda light chain.
* [https://www.imgt.org/ IMGT]
* LYRA selected frameworks 3H42 (80.5% identity) and 1W72 (85.7% identity).
* [https://opig.stats.ox.ac.uk/webapps/sabdab-sabpred/sabpred/abodybuilder2/ ABodyBuilder2]
* Five distinct structural templates were used for framework, loop and packing modelling.
* All selected loop cores have matching target/template lengths, but CDR-L1 differs in its canonical structure classification.
* CDR-L2 has the lowest loop-core sequence identity, while CDR-L3 has the greatest number of residue substitutions.
* CDR-L3 is the longest loop; the apparent extent of protrusion depends on the representation and viewing direction.
* CDR mutations can influence binding by changing side-chain chemistry or loop conformation, but effects on affinity require experimental validation.
* The electrostatic properties of the binding site reflect the positions of charged residues, especially aspartates in the light-chain CDRs.
* Template-based and deep-learning predictions generally agree on the immunoglobulin framework but may differ in CDR conformations.

Latest revision as of 04:00, 21 October 2026

Antibody Structure Modelling — Answers

These answers refer to the SI135 antibody and the LYRA model generated from its heavy- and light-chain variable-region sequences. Residue numbering is identified as IMGT or PDB numbering where relevant.

https://services.healthtech.dtu.dk/cgi-bin/webface2.cgi?jobid=6AD8166000282F67166ED625&wait=20

Part 1 — Antibody modelling with LYRA

Q1. Framework template similarity

LYRA selected the following templates for the antibody frameworks:

Chain Selected template Sequence identity BLOSUM score
Heavy chain (VH) 3H42 80.5% 514
Light chain (VL) 1W72 85.7% 518

The heavy-chain candidate 2UZI has a slightly higher sequence identity (81.7%), but a lower BLOSUM score (489) than 3H42. Thus, the template with the highest percentage of identical amino acids is not necessarily the one selected for modelling. Template selection also considers sequence similarity and the compatibility of the antibody's structural features.

Q2. Light-chain type

SI135 has a lambda (λ) light chain. This is not the most common light-chain type in humans: approximately 60% of human antibodies have kappa (κ) light chains and 40% have lambda (λ) light chains, although the proportions vary.

Q3. Differences between the target and template sequences

The target and framework templates are relatively similar, but there are substitutions in both framework and CDR regions. Particularly informative differences in the selected loop-template alignments include:

Region Template → SI135 Possible consequence
H1 S → T Conservative change between polar residues
H2 S → N Changes side-chain size and hydrogen-bonding possibilities
H3 R → N Removes a positive charge
H3 Q → T Changes side-chain size and hydrogen-bonding properties
L2 D → Y Removes a negative charge and introduces a bulky aromatic group
L3 L → S Replaces a hydrophobic residue with a polar residue
L3 S → D Introduces a negatively charged residue
L3 A → H Introduces a larger side chain that may be protonated
L3 D → P Removes a negative charge and introduces a conformationally restricted residue

The D → Y change in L2 is particularly non-conservative (BLOSUM62 score −3). The D → P change in L3 may also matter because proline strongly restricts backbone geometry. Changes at buried framework positions can influence stability, whereas changes in exposed CDR positions can influence the chemistry and shape of the binding site. The likely effect cannot be inferred from the substitution score alone.

Q4. CDR lengths and modelling accuracy

All six selected LYRA loop templates have the same loop-core length as their corresponding SI135 loops.

Loop PDB template Template sequence SI135 sequence Length
H1 3H42 GFTFSSY GFTFSTY 7
H2 3H42 SSSS SSSN 4
H3 2NR6 VRQMD VNTMD 5
L1 2G75 GNNIGSKS GNNIGSKS 8
L2 1W72 DDS YDN 3
L3 3GHB WDSGLSADW WDSGSDHPW 9

These are the loop-core sequences reported in the LYRA PDB annotations; broader CDR definitions include additional flanking residues.

Matching lengths make template-based modelling easier because insertions or deletions are not needed within the selected loop cores. However, matching length does not guarantee matching conformation. In particular, L1 has template canonical structure class 7 but predicted class 8, even though its loop-core sequence is identical. This suggests that its modelled backbone should be interpreted cautiously.

Q5. Number of structural templates

LYRA used five distinct PDB templates:

PDB Region or regions modelled
3H42 Heavy-chain framework, H1, H2 and heavy/light-chain packing
2NR6 H3
1W72 Light-chain framework and L2
2G75 L1
3GHB L3

These structures fill nine framework, loop and packing assignments, but some PDB entries are reused.

The lowest percentage sequence identity among the selected loop cores occurs in L2: only 1 of its 3 residues is identical to the template (33.3%). In contrast, L3 has the largest absolute number of substitutions: 4 of its 9 residues differ from the selected template (55.6% identity). Both are comparatively uncertain regions, but for different reasons.

Part 2 — Exploring the antibody structure in PyMOL

Q6. Shape of the antigen-binding site

The predicted antigen-binding surface is best described as a shallow pocket or groove. The CDR loops form an uneven surface with a depression between protruding regions rather than a completely flat plane.

The classification is qualitative: the appearance changes with the orientation of the model and how its molecular surface is displayed. The surface shape alone does not identify the antigen or establish binding specificity.

Q7. Longest and most protruding loop

CDR-L3 is the longest loop in the selected LYRA model, with a 9-residue loop core (or 10 residues in the corresponding PDB loop selection including a flanking residue). CDR-L1 is the next longest in these definitions.

CDR-L3 is also a conspicuous protruding feature of the binding site. Depending on the viewing direction and whether backbone or surface protrusion is considered, H2 may appear to extend further than L3. Thus, the longest loop is not necessarily the one with the greatest height above the binding surface.

This is not the usual pattern emphasized for human antibodies, where CDR-H3 is commonly the most variable and often a prominent part of the binding site. In SI135, CDR-H3 is relatively short.

Part 3 — Somatic mutations

Q8. Mutations within or near the CDRs

The germline comparison identifies the following amino acid substitutions in the CDR regions (IMGT numbering; germline residue → SI135 residue):

Chain Region Mutation Interpretation
Heavy CDR-H1 S36T Conservative polar substitution
Heavy CDR-H2 S63N Changes side-chain geometry and hydrogen bonding
Heavy CDR-H2 Y64S Removes a bulky aromatic side chain
Light CDR-L2 S65N Changes side-chain geometry and hydrogen bonding
Light CDR-L3 S110G Introduces glycine, which increases local backbone flexibility

A further heavy-chain framework substitution, Y67C, lies close to CDR-H2 and may influence the local structure. Other framework substitutions are present but are not necessarily directly involved in antigen contacts.

The strongest candidates for influencing antigen binding are Y64S in CDR-H2 and potentially Y67C immediately outside this loop, because they remove aromatic residues. The CDR substitutions S63N, S65N and S110G could also influence the local geometry or hydrogen-bonding interactions. In the BLOSUM62 matrix S → N has a positive score (+1), so it is not an especially drastic substitution by that measure alone.

Whether any mutation actually changes antigen affinity depends on its position and interactions in the three-dimensional complex. Mutations relative to germline should not be confused with the differences between SI135 and the LYRA structural templates.

Part 4 — Electrostatic properties of the antigen-binding site

Q9. Charged CDR residues

The important charged side chains are lysine (K) and arginine (R), which are usually positive, and aspartate (D) and glutamate (E), which are usually negative. Histidine (H) may carry a positive charge depending on its local environment and pH.

The main contributors in the LYRA PDB loop selections are:

Loop Charged residues LYRA PDB positions
H1 No K, R, D or E —
H2 No K, R, D or E —
H3 One D (negative) H101
L1 One K (positive) L31
L2 Two D residues (negative) L51, L53
L3 Two D residues (negative); one potentially protonated H L92, L95A; H at L95B

The short LYRA L2 loop-core sequence YDN contains one D; the corresponding PDB loop selection includes an additional flanking D at residue L53. This explains why either one or two aspartates may be counted depending on the CDR boundaries used.

The negatively charged residues in L2 and L3 can contribute to a negative electrostatic patch around parts of the binding site. However, potential depends on solvent exposure, protonation and the three-dimensional arrangement of residues, not only on their number.

In a common electrostatic coloring convention, red indicates negative potential and blue indicates positive potential. The result from PyMOL's vacuum potential calculation is a qualitative representation.

Q10. Introducing a positive charge (optional)

Changing an exposed acidic residue near the centre of the antigen-binding site to lysine or arginine should make the local electrostatic potential more positive. For example, D → K replaces a negatively charged side chain with a positively charged one.

After recalculating the surface potential, the region around the mutation would be expected to shift towards less red or more blue, depending on the color scale used. The effect can remain local and may be less obvious when other nearby charged residues dominate the surface potential.

The reverse experiment also illustrates the same principle: replacing K31 in CDR-L1 with alanine removes a positive charge and can reduce a local positive electrostatic patch. A change in surface potential is not evidence by itself of improved or reduced antigen binding.

Part 5 — Comparing antibody modelling approaches

Q11. LYRA versus ABodyBuilder2

Both LYRA and ABodyBuilder2 predict a similar overall immunoglobulin fold for the heavy- and light-chain variable domains. The conserved framework beta-sheets are broadly consistent between the models.

Differences are most likely to be visible in the CDR loops, whose local backbone conformations may vary between a template-based and a deep-learning prediction. Comparisons of SI135 models show deviations in individual loops, particularly around CDR-H3 and CDR-L3; the local conformation of other loops, including L1, may also differ.

LYRA ABodyBuilder2
Template-based homology modelling Deep-learning-based structure prediction
Uses selected framework and CDR structural templates Predicts antibody structure from the amino acid sequences
Accuracy depends in part on template suitability Reports prediction-error estimates for different structural regions

When the structures are superimposed, the frameworks are expected to agree more closely than the variable loops. Any differences should be interpreted as model uncertainty, not as proof that one model is correct. Neither prediction alone establishes the experimentally observed antibody conformation or its antigen specificity.

Summary

  • The SI135 antibody contains a lambda light chain.
  • LYRA selected frameworks 3H42 (80.5% identity) and 1W72 (85.7% identity).
  • Five distinct structural templates were used for framework, loop and packing modelling.
  • All selected loop cores have matching target/template lengths, but CDR-L1 differs in its canonical structure classification.
  • CDR-L2 has the lowest loop-core sequence identity, while CDR-L3 has the greatest number of residue substitutions.
  • CDR-L3 is the longest loop; the apparent extent of protrusion depends on the representation and viewing direction.
  • CDR mutations can influence binding by changing side-chain chemistry or loop conformation, but effects on affinity require experimental validation.
  • The electrostatic properties of the binding site reflect the positions of charged residues, especially aspartates in the light-chain CDRs.
  • Template-based and deep-learning predictions generally agree on the immunoglobulin framework but may differ in CDR conformations.